期刊文献+

毛细支气管炎患儿肺功能特点及应用吸入性糖皮质激素的疗效 被引量:7

Characteristics of Lung Function of Children with Bronchiolitis and Therapeutic Effect of Inhalational Glucocorticoid
在线阅读 下载PDF
导出
摘要 目的探讨毛细支气管炎患儿肺功能特点及吸入性布地奈德(普米克令舒)、丙酸氟替卡松(辅舒酮)治疗毛细支气管炎的疗效。方法毛细支气管炎患儿100例分为观察组、对照组。2组均采用综合治疗,观察组加用普米克令舒/辅舒酮吸入。测定治疗前、出院时、出院后3个月二组患儿潮气呼吸肺功能;观察其急性期症状缓解情况;回访出院后3个月及1a后健康情况。30例同龄健康儿童的肺功能为健康对照组。结果1.观察组在改善临床症状、减少住院天数上优于对照组(Pa<0.05)。2.观察组出院后3个月,咳嗽、气喘发作次数较对照组减少(Pa<0.05)。3.出院时观察组潮气量(TV/kg)的增加、呼吸频率(RR)的下降优于对照组(Pa<0.05);观察组25%潮气量时的潮气呼气流速(TEF25%)、达峰时间比(TPEF/TE)、达峰容积比(VPEF/VE)较入院时上升(Pa<0.05),3个月后恢复正常,与健康对照组比较无明显差异(P>0.05)。对照组出院时TEF25%、TPEF/TE、VPEF/VE与入院时无明显改变(Pa>0.05),3个月后仍未恢复正常。4.随访1a,观察组发展为支气管哮喘的几率低于对照组(P<0.05)。5.毛细支气管炎急性期临床评分与TPEF/TE、VPEF/VE呈负相关,临床评分数值越高,病情越重,TPEF/TE、VPEF/VE值越低。结论1.毛细支气管炎患儿用吸入性糖皮质激素早期干预治疗,对急性期症状的缓解、降低发展为支气管哮喘的几率有较好疗效。2.TPEF/TE及VPEF/VE可判断毛细支气管炎呼吸道阻塞严重程度。 Objective To explore the feature of lung function of children with bronchiolitis, and investigate the therapeutic effect of Budesonide(Pulmicort) and fluticasone propionate( Flixotide). Methods One hundred children with bronchiolitis were randomly divided into observe group and control group equally. The observe group treated with additional Pulmicort in hospital and utilize mist - container to inhalate Flixotide after discharged. The lung functions were determined before the therapy, post - therapy (discharge) ,3 months post - therapy. The symptomatic relieve of the acute stage.3 months after discharged and 1 year physical follow - up were observed. Thirty healthy even - aged children were taken as normal group. Results 1. Improving of clinical symptom and tmspitalization in inhalation group were significantly decurtated ( Pa 〈0. 05 ). 2. After 3 months therapy,the frequence of cough and asthma outbreak in observe group was lower than that of control group( Pa 〈 0. 05 ). 3. Post - therapy (discharge) : VT ascend, RR descended in inhalation group were more significantly than those of control group ( Pa 〈0. 05 ), the TEF25% , VPEF/VE and TPEF/TE of inhalation group ascend( Pa〈0. 05 ). After 3 months therapy:No significant differences were found compared to the normal group( P 〉 0. 05 ). Post - therapy( discharge ) :No significant difference in TEF25%, VPTEF/VE and TPEF/TE of control group (Pa〉 0. 05 ). After 3 months therapy : The TEF25% , VPEF/VE and TPEF/TE of control group were different from those of normal group statistically. 4. After I year, the incidence of asthma of observe group was significantly lower than that of control group( P 〈 0. 05 ). 5. The clinical evaluation score of bronchiolitis in acute stage characterized negative cot'relation to the TPEF/TE,VPEF/VE and TEF25 % which means the score higher, the condition more severe and the TPEF/TE,VPEF/VE and TEF25% lower. Condusions 1. In bronchiolitis children, early intervention treatment with inhalational glucocorticoid is effective not only to the symptomatic relieves in the acute stage but also to debase the odds of advancing to bronchus asthma. 2. TPEF/TE and VPEF/VE are correlation to the severity of bronchiolitis,an evaluate the bronchoilitis airway obstruction.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2007年第22期1703-1704,1756,共3页 Journal of Applied Clinical Pediatrics
关键词 毛细支气管炎 肺功能 糖皮质激素 bronchiolitis lung function glucocorticoid
  • 相关文献

参考文献12

二级参考文献52

  • 1阮为勇,郑意楠,李海浪.盐酸氨溴索支气管肺泡灌洗治疗新生儿胎粪吸入综合征疗效观察[J].实用儿科临床杂志,2004,19(10):880-881. 被引量:14
  • 2聂爱玲,高振芳,刘小军.氨溴索注射液治疗慢性阻塞性肺病20例[J].新乡医学院学报,2004,21(6):471-472. 被引量:18
  • 3中华人民共和国卫生部.小儿四病防治方案(二),小儿肺炎防治方案[J].中华儿科杂志,1987,25(1):47-47.
  • 4Hall CB. Respiratory syncytial virus and parainfluenza virus[J]. N Engl J Med, 2001,344(25) :1917-1928.
  • 5Constantopoulos AG, Kafetzis DA, Syrogiannopoulos GA, et al. Burden of respiratory syncytial viral infections on paediatric hespitals: a two-year prospective epidemiological study[J]. Eur J Clin Microbial Infect Dis,2002,21 (2) : 102107.
  • 6Kaneko M, Watanabe J, Kuwahara Met al. Impact of respiratory syncytial virus infection as a cause of lower respiratory tract infection in children younger than 3 years of age in Japan[J]. J Infect, 2002,44(4) :240-243.
  • 7Law BJ,Carbonell-Estrany X,Simoes EA.An update on respiratory syncytial virus epidemiology: a developed country perspective [J]. Respir Med,2002,96( Suppl B) :s1-7.
  • 8Welliver RC. Respiratory syncytial virus and other respiratory viruses[J]. Pediatr Infect Dis J, 2003,22(Suppl 2) :s6-12.
  • 9Holt PG, Sly PD. Interactions between respiratory tract infections and atopy in the aetiology of asthma[J]. Eur Respir J, 2002,19(3) :538-545.
  • 10Schauer U, Hoffjan S,Bittscheidt J et al. RSV broncliiolitis and risk of wheeze and allergic sensitisation in the first year of life[J]. Eur Respir J. 2002.20 (5) : 1277-1283.

共引文献4571

同被引文献72

引证文献7

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部